Results 1 to 10 of about 15,421,997 (282)

Pharmacotherapy treatment of stimulant use disorder [PDF]

open access: yesMental Health Clinician, 2021
Stimulant use disorder (SUD) is a public health problem in the United States that is associated with increased morbidity and mortality. Psychosocial interventions, such as cognitive behavioral therapy and contingency management, are the main treatment ...
Mei T. Liu, PharmD, BCPP
doaj   +6 more sources

Transcranial Stimulation for the Treatment of Stimulant Use Disorder [PDF]

open access: yesNeurology International, 2023
The increasing prevalence of stimulant use disorder (StUD) involving methamphetamine and cocaine has been a growing healthcare concern in the United States.
Amber N. Edinoff   +12 more
doaj   +4 more sources

Psychosocial interventions for stimulant use disorder. [PDF]

open access: yesCochrane Database Syst Rev
Stimulant use disorder is a continuously growing medical and social burden without approved medications available for its treatment. Psychosocial interventions could be a valid approach to help people reduce or cease stimulant consumption. This is an update of a Cochrane review first published in 2016.To assess the efficacy and safety of psychosocial ...
Minozzi S   +4 more
europepmc   +5 more sources

The use of Drosophila to study sleep impairments in stimulant use disorder [PDF]

open access: yesFrontiers in Cell and Developmental Biology
Stimulant drugs like cocaine and methamphetamine acutely enhance the release of monoamine neurotransmitters, particularly dopamine, to induce euphoria, motivation, hyperlocomotion, and strong sleep suppression.
Madelyn Miles   +8 more
doaj   +2 more sources

Validation of Two Diagnostic Assessments for Opioid and Stimulant Use Disorder for Use by Non‐Clinicians [PDF]

open access: yesPsychiatric Research and Clinical Practice, 2023
Objective The United States is in the fourth wave of the opioid epidemic marked by the increase in fentanyl and co‐occurring stimulant use related overdose deaths.
Angela Di Paola   +2 more
doaj   +2 more sources

Rationale, design and methods of the Cul-CM study: a protocol for cultural adaptation of contingency management in adults with stimulant use disorder [PDF]

open access: yesBMJ Open
Introduction Stimulant use disorder is a growing contributor to drug poisoning and mortality in the USA, with disproportionate impact on black communities driven by stimulant-opioid polysubstance use and other structural barriers to treatment ...
Theddeus Iheanacho   +6 more
doaj   +2 more sources

The mesocorticolimbic system in stimulant use disorder. [PDF]

open access: yesMol Psychiatry
Abstract Stimulant Use Disorder (StUD) is a pervasive and extremely dangerous form of addiction for which there are currently no approved medications. Discovering treatments will require a deep understanding of the neural mechanisms underlying the behavioral effects of stimulant drugs.
London ED   +3 more
europepmc   +3 more sources

Co‐occurring opioid and stimulant use disorder and the relationship to severe maternal morbidity [PDF]

open access: yesPregnancy
Introduction To evaluate the impact of the use of opioids, stimulants, or both on the rates of various severe maternal morbidity (SMM) events during inpatient delivery‐related hospitalizations among patients with substance use disorder (SUD).
Tucker E. Doiron   +3 more
doaj   +2 more sources

Prescribed medications for patients with amphetamine-type stimulant use disorder seen in rural-serving Pacific Northwest primary care clinics [PDF]

open access: yesAddiction Science & Clinical Practice
Background Amphetamine-type stimulant use and overdoses have increased sharply across the US in recent years, largely driven by methamphetamine. Increased access to treatments for amphetamine-type stimulant use disorder (AT-StUD), including in primary ...
Megan J. Yerton   +4 more
doaj   +2 more sources

SIPD or psychotic disorder with stimulant use

open access: yesSchizophrenia Research: Cognition
Tania Lecomte   +9 more
doaj   +3 more sources

Home - About - Disclaimer - Privacy